T. Rowe Price Associates’s NRC Health Common Stock NRC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,066	Closed	-$206K	–	3122
2025 Q3	$206K	Hold	16,066	–	–	﹤0.01%	2783
2025 Q2	$270K	Buy	16,066 +951	+6%	+$12.8K	﹤0.01%	2574
2025 Q1	$194K	Buy	15,115 +865	+6%	+$13.9K	﹤0.01%	2656
2024 Q4	$252K	Buy	14,250 +752	+6%	+$14.3K	﹤0.01%	2588
2024 Q3	$309K	Buy	13,498 +144	+1%	+$3.25K	﹤0.01%	2464
2024 Q2	$307K	Buy	13,354 +668	+5%	+$20.6K	﹤0.01%	2402
2024 Q1	$503K	Buy	12,686 +4,637	+58%	+$183K	﹤0.01%	2208
2023 Q4	$319K	Buy	8,049 +235	+3%	+$9.84K	﹤0.01%	2354
2023 Q3	$347K	Buy	7,814 +447	+6%	+$19.5K	﹤0.01%	2281
2023 Q2	$321K	Buy	7,367 +165	+2%	+$7.25K	﹤0.01%	2330
2023 Q1	$314K	Sell	7,202 -2,454	-25%	-$108K	﹤0.01%	2324
2022 Q4	$360K	Buy	9,656 +231	+2%	+$8.94K	﹤0.01%	2300
2022 Q3	$376K	Buy	9,425 +847	+10%	+$31.4K	﹤0.01%	2272
2022 Q2	$328K	Buy	8,578 +1,571	+22%	+$56.8K	﹤0.01%	2407
2022 Q1	$278K	Buy	7,007 +282	+4%	+$11K	﹤0.01%	2580
2021 Q4	$279K	Sell	6,725 -240	-3%	-$10.4K	﹤0.01%	2617
2021 Q3	$294K	Hold	6,965	–	–	﹤0.01%	2588
2021 Q2	$320K	Buy	6,965 +303	+5%	+$14.4K	﹤0.01%	2575
2021 Q1	$312K	Buy	+6,662	New	+$324K	﹤0.01%	2555